Clinical trial
GW786034 in Treating Patients With Advanced Solid Tumors
NCT00060151 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00060151 |
|---|---|
| Title | GW786034 in Treating Patients With Advanced Solid Tumors |
| Official title | A Phase I, Open Label, Multiple Dose, Dose Escalation Study OF GW786034 In Patients With Solid Tumors |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | pazopanib hydrochloride |
| Start date | Dec 1, 2002 |
| Completion | Jun 1, 2009 |
| First posted | May 7, 2003 |
| Last update posted | Sep 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: